Tirzepatide
Tirzepatide is a pharmaceutical drug with 195 clinical trials. Currently 87 active trials ongoing. Historical success rate of 98.6%.
Success Metrics
Based on 70 completed trials
Phase Distribution
Phase Distribution
33
Early Stage
59
Mid Stage
77
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
94.6%
70 of 74 finished
5.4%
4 ended early
87
trials recruiting
195
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Tirzepatide in MetALD
Tirzepatide for Treatment of CCCA
A Study to Evaluate ALN-2232 in Participants With Obesity
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
Clinical Trials (195)
Tirzepatide in MetALD
Tirzepatide for Treatment of CCCA
A Study to Evaluate ALN-2232 in Participants With Obesity
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
Tirzepatide for Ileal Pouch-anal Anastomosis (IPAA) and Chronic High Bowel Frequency (I8F-NS-X008)
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot Trial
Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With Obesity
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial
Tirzepatide in Idiopathic Intracranial Hypertension Trial
Tirzepatide s Dopaminergic Effects in Alcohol Use Disorders (AUD)
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 195